Biogen appoints insider as CFO after Michael McDonnell to retire next year
Adds background in paragraph 3, details on Kramer in paragraph 6
Oct 28 (Reuters) -Biogen BIIB.O said on Monday insider Robin Kramer will take over as the drugmaker's finance chief after incumbent Michael McDonnell retires at the end of February next year.
The appointment of Kramer, who joined Biogen in 2018 and currently serves as its chief accounting officer, comes at a time when the company is aiming for a turnaround.
Biogen has relied on cost cuts, multiple acquisitions and a narrowed focus on new launches to boost profit since CEO Christopher Viehbacher took the top role in 2022.
McDonnell, who has been the company's chief financial officer since August 2020, plans to retire on Feb. 28. He has played a pivotal role in the drugmaker's recent acquisitions.
"Her (Kramer) deep understanding of our business, coupled with her breadth of knowledge and leadership experience give me great confidence in her as our next CFO," Viehbacher said.
Before joining Biogen, Kramer held senior finance roles at Hertz Global Holdings HTZ.O and the Gillette Company, among others.
Shares of Biogen, which is set to report its third-quarter results on Wednesday, have fallen about 29% so far this year. The stock was marginally up in early trading on Monday.
Reporting by Sriparna Roy in Bengaluru; Editing by Shilpi Majumdar
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
